Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in AdultsDick Menzies, Andrea Benedetti, Mênonli Adjobimey et al.|New England Journal of Medicine|2018Cited by 392
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studiesLeonardo Martínez, Afrânio Lineu Kritski, Philip C. Hill et al.|The Lancet Respiratory Medicine|2024Cited by 47
Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different SettingsMayara Lisboa Bastos, Dick Menzies, Jonathon R. Campbell et al.|Annals of Internal Medicine|2020Cited by 31
Safety and Efficacy of Rifampin or Isoniazid Among People With <i>Mycobacterium tuberculosis</i> Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized TrialsJonathon R. Campbell, Dick Menzies, Hamdan Al‐Jahdali et al.|Clinical Infectious Diseases|2020Cited by 27